Oral Contraceptive
14
0
0
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
36%
5 trials in Phase 3/4
36%
4 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (14)
Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation
Social Media Usage in Adolescent Girls
A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives
A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women
Evaluation of Hormonal Contraceptive Treatments in Obese Women
Oral Contraceptive (OC) Progestin Dose and Breast Proliferation
Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache
A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
Comparative Trial in Hormone Withdrawal Associated Symptoms
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition
TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.
Bleeding Pattern Study
Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception